Nasdaq Stockholm

Repurchases of shares by Concentric AB during week 11, 2024

Retrieved on: 
Tuesday, March 19, 2024

All acquisitions have been carried out on Nasdaq Stockholm by Skandinaviska Enskilda Banken AB on behalf of Concentric.

Key Points: 
  • All acquisitions have been carried out on Nasdaq Stockholm by Skandinaviska Enskilda Banken AB on behalf of Concentric.
  • Following the above acquisitions, Concentric's holding of own shares amounts to 1,148,253 shares as of 15 March 2024.
  • The total number of shares in Concentric, including the own shares, is 38,297,600 and the number of outstanding shares, excluding the own shares, is 37,149,347.
  • The information was submitted for publication, through the agency of the contact persons set out above, at 08:00 CET on 19th March 2024.

Orexo successfully issues senior secured callable floating rate social bonds of SEK 500 m and announces results of the tender offer for its existing bonds

Retrieved on: 
Wednesday, March 13, 2024

UPPSALA, Sweden, March 13, 2024 /PRNewswire/ -- Orexo AB (publ), ("Orexo" or the "Company") (STO:ORX) (OTCQX:ORXOY) has successfully issued new senior secured callable floating rate social bonds in an amount of SEK 500 million and with a tenor of four years (the "New Social Bonds").

Key Points: 
  • UPPSALA, Sweden, March 13, 2024 /PRNewswire/ -- Orexo AB (publ), ("Orexo" or the "Company") (STO:ORX) (OTCQX:ORXOY) has successfully issued new senior secured callable floating rate social bonds in an amount of SEK 500 million and with a tenor of four years (the "New Social Bonds").
  • Orexo intends to apply for admission to trading of the New Social Bonds on the sustainable bonds list of Nasdaq Stockholm.
  • The issuance of the New Social Bonds was oversubscribed and received interest from both Nordic and international institutional investors.
  • Conditional upon settlement of the New Social Bonds, Orexo further intends to exercise its right to make an early redemption of the Existing Bonds not being repurchased in the Tender Offer, in accordance with the terms and conditions of the Existing Bonds.

Orexo successfully issues senior secured callable floating rate social bonds of SEK 500 m and announces results of the tender offer for its existing bonds

Retrieved on: 
Wednesday, March 13, 2024

UPPSALA, Sweden, March 13, 2024 /PRNewswire/ -- Orexo AB (publ), ("Orexo" or the "Company") (STO:ORX) (OTCQX:ORXOY) has successfully issued new senior secured callable floating rate social bonds in an amount of SEK 500 million and with a tenor of four years (the "New Social Bonds").

Key Points: 
  • UPPSALA, Sweden, March 13, 2024 /PRNewswire/ -- Orexo AB (publ), ("Orexo" or the "Company") (STO:ORX) (OTCQX:ORXOY) has successfully issued new senior secured callable floating rate social bonds in an amount of SEK 500 million and with a tenor of four years (the "New Social Bonds").
  • Orexo intends to apply for admission to trading of the New Social Bonds on the sustainable bonds list of Nasdaq Stockholm.
  • The issuance of the New Social Bonds was oversubscribed and received interest from both Nordic and international institutional investors.
  • Conditional upon settlement of the New Social Bonds, Orexo further intends to exercise its right to make an early redemption of the Existing Bonds not being repurchased in the Tender Offer, in accordance with the terms and conditions of the Existing Bonds.

Immunovia announces updated financial calendar

Retrieved on: 
Tuesday, March 12, 2024

Immunovia AB is a diagnostic company whose mission is to increase survival rates for patients with pancreatic cancer through early detection.

Key Points: 
  • Immunovia AB is a diagnostic company whose mission is to increase survival rates for patients with pancreatic cancer through early detection.
  • Immunovia is focused on the development and commercialization of simple blood-based testing to detect proteins and antibodies that indicate a high-risk individual has developed pancreatic cancer.
  • Immunovia collaborates and engages with healthcare providers, leading experts and patient advocacy groups to make its test available to individuals at increased risk for pancreatic cancer.
  • The company estimates that in the USA, 1.8 million individuals are at high-risk for pancreatic cancer and could benefit from annual surveillance testing.

Immunovia announces updated financial calendar

Retrieved on: 
Tuesday, March 12, 2024

Immunovia AB is a diagnostic company whose mission is to increase survival rates for patients with pancreatic cancer through early detection.

Key Points: 
  • Immunovia AB is a diagnostic company whose mission is to increase survival rates for patients with pancreatic cancer through early detection.
  • Immunovia is focused on the development and commercialization of simple blood-based testing to detect proteins and antibodies that indicate a high-risk individual has developed pancreatic cancer.
  • Immunovia collaborates and engages with healthcare providers, leading experts and patient advocacy groups to make its test available to individuals at increased risk for pancreatic cancer.
  • The company estimates that in the USA, 1.8 million individuals are at high-risk for pancreatic cancer and could benefit from annual surveillance testing.

Volvo Group signs agreement with Westport for joint venture to reduce CO2 emissions from long haul transport

Retrieved on: 
Monday, March 11, 2024

The closing of the joint venture is subject to certain closing conditions, including regulatory and government approvals.

Key Points: 
  • The closing of the joint venture is subject to certain closing conditions, including regulatory and government approvals.
  • It is anticipated that the joint venture will become operational following the formal closing which is expected in the second quarter of 2024.
  • As previously announced, Westport will contribute certain HPDI assets and opportunities, including related fixed assets, intellectual property, and business, into the joint venture.
  • Founded in 1927, the Volvo Group is committed to shaping the future landscape of sustainable transport and infrastructure solutions.

Sivers Semiconductors announces an expanded loan facility of SEK 50 million

Retrieved on: 
Monday, March 11, 2024

KISTA, Sweden, March 11, 2024 /PRNewswire/ -- Sivers Semiconductors AB (STO: SIVE), (the "Company"), a leading supplier of integrated chips and modules for the most advanced communications and sensor solutions, has, according to previous communication in connection with the 2023 fourth-quarter report, agreed to entered into a loan agreement with Formue Nord and partners extending the previous SEK 75 million facility. The new SEK 50 million loan facility includes a SEK 35 million convertible loan at a fixed conversion rate of 4.86 SEK, corresponding to 125% of the closing price for the Company's ordinary shares on Nasdaq Stockholm on 8 March 2023. The Company anticipates this financing, and its own cash flow will fully address funding for at least 2024, without the need for any further capital contributions from shareholders. 

Key Points: 
  • The new SEK 50 million loan facility includes a SEK 35 million convertible loan at a fixed conversion rate of 4.86 SEK, corresponding to 125% of the closing price for the Company's ordinary shares on Nasdaq Stockholm on 8 March 2023.
  • "With this new loan facility, we have now secured our funding base, providing us with the resources needed to meet market demands.
  • The directed convertible issue is a prerequisite for obtaining the SEK loan facility.
  • With innovation at our core, Sivers Semiconductors is committed to delivering bespoke, high-performance solutions for a better-connected and safer world.

Millicom (Tigo) share repurchase activity

Retrieved on: 
Saturday, March 9, 2024

All purchases were carried out on Nasdaq Stockholm by Citigroup Global Markets Limited on behalf of Millicom.

Key Points: 
  • All purchases were carried out on Nasdaq Stockholm by Citigroup Global Markets Limited on behalf of Millicom.
  • Following the purchases, Millicom holds 957,733 treasury shares as of March,8 2024.
  • The repurchase program is being executed consistent with the provisions of Article 5 of MAR and the Commission Delegated Regulation No 2016/1052 (“Safe Harbour Regulation”).
  • For information about all transactions carried out under the repurchase program, refer to Nasdaq Stockholm’s website: http://www.nasdaqomx.com/transactions/markets/nordic/corporate-actions/s...

Millicom (Tigo) share repurchase activity

Retrieved on: 
Friday, March 1, 2024

All purchases were carried out on Nasdaq Stockholm by Citigroup Global Markets Limited on behalf of Millicom.

Key Points: 
  • All purchases were carried out on Nasdaq Stockholm by Citigroup Global Markets Limited on behalf of Millicom.
  • Following the purchases, Millicom holds 907,049 treasury shares as of March,1 2024.
  • The repurchase program is being executed consistent with the provisions of Article 5 of MAR and the Commission Delegated Regulation No 2016/1052 (“Safe Harbour Regulation”).
  • For information about all transactions carried out under the repurchase program, refer to Nasdaq Stockholm’s website: http://www.nasdaqomx.com/transactions/markets/nordic/corporate-actions/s...

Millicom (Tigo) share repurchase activity

Retrieved on: 
Friday, February 23, 2024

All purchases were carried out on Nasdaq Stockholm by Citigroup Global Markets Limited on behalf of Millicom.

Key Points: 
  • All purchases were carried out on Nasdaq Stockholm by Citigroup Global Markets Limited on behalf of Millicom.
  • Following the purchases, Millicom holds 1,631,620 treasury shares as of February 23, 2024.
  • The repurchase program is being executed consistent with the provisions of Article 5 of MAR and the Commission Delegated Regulation No 2016/1052 (“Safe Harbour Regulation”).
  • For information about all transactions carried out under the repurchase program, refer to Nasdaq Stockholm’s website: http://www.nasdaqomx.com/transactions/markets/nordic/corporate-actions/s...